Cite

HARVARD Citation

    Fujiwara, K. et al. (2020). Development and functional analysis of an anticancer T‐cell medicine with immune checkpoint inhibitory ability. IUBMB life. 72 (8), pp. 1649-1658. [Online]. 
  
Back to record